Tatar Sumandjar
Tatar Sumandjar has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Densi Selpia Sopianti
Doctoral Program of Medical Sciences, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia. Jalan Ir. Sutami 36A Surakarta Jawa-57126, Tengah Indonesia. Department of Pharmacy, Sekolah Tinggi Kesehatan Al-Fatah, Bengkulu, Indonesia
1 shared publication - Dhani Redhono Harioputro
Internal Medicine Department, Faculty of Medicine, Universitas Sebelas Maret Surakarta, Indonesia
1 shared publication - Eti Poncorini Pamungkasari
Universitas Sebelas Maret
1 shared publication - Evi Nurhayatun
Department of Internal Medicine, Dr. Moewardi Hospital, Surakarta
1 shared publication - Ida Nurwati
Universitas Sebelas Maret
1 shared publication - Mentari Maratus Sholihah
Department of Internal Medicine, Dr. Moewardi Hospital, Surakarta City, Central Java, Indonesia
1 shared publication
Latest Publications
- 14 September 2026
- Published by CMMB-Colegiul Medicilor Municipiul Bucuresti in Medicina Moderna - Modern Medicine
- Vol. 33 (3) , 217-225
Cryptosporidiosis in Immunocompromised Population: A Review of Neglected Global Disease
Cryptosporidiosis is a diarrheal disease caused by the protozoan Cryptosporidium spp. and is a major cause of morbidity and mortality in children and individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients. This infection is transmitted via the fecal-oral route, primarily through contaminated water or food, with the most common species being C. hominis and C. parvum. Its pathogenesis involves invasion of intestinal epithelial cells, leading to impaired absorption and secretory diarrhea. Clinical symptoms range from asymptomatic to severe chronic diarrhea in immunocompromised patients. Diagnosis is made through microscopic examination, immunofluorescence, or PCR to detect oocysts or parasite DNA, with varying sensitivities. The mainstay of therapy is nitazoxanide, although its effectiveness is still limited in immunocompromised patients. Infection prevention emphasizes clean water, sanitation, and immune system strengthening, including the use of antiretroviral therapy for HIV patients. Thus, cryptosporidiosis remains a global health challenge that requires attention to early diagnosis, environmental control, and the development of more effective therapies in the future.
- 14 September 2026
- Published by CMMB-Colegiul Medicilor Municipiul Bucuresti in Medicina Moderna - Modern Medicine
- Vol. 33 (3) , 217-225
Cryptosporidiosis in Immunocompromised Population: A Review of Neglected Global Disease
Cryptosporidiosis is a diarrheal disease caused by the protozoan Cryptosporidium spp. and is a major cause of morbidity and mortality in children and individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients. This infection is transmitted via the fecal-oral route, primarily through contaminated water or food, with the most common species being C. hominis and C. parvum. Its pathogenesis involves invasion of intestinal epithelial cells, leading to impaired absorption and secretory diarrhea. Clinical symptoms range from asymptomatic to severe chronic diarrhea in immunocompromised patients. Diagnosis is made through microscopic examination, immunofluorescence, or PCR to detect oocysts or parasite DNA, with varying sensitivities. The mainstay of therapy is nitazoxanide, although its effectiveness is still limited in immunocompromised patients. Infection prevention emphasizes clean water, sanitation, and immune system strengthening, including the use of antiretroviral therapy for HIV patients. Thus, cryptosporidiosis remains a global health challenge that requires attention to early diagnosis, environmental control, and the development of more effective therapies in the future.
- Open Access
- 17 January 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (2) , 623-650
Caesalpinia bonduc (L) Roxb Seed Extract Dosage and Sex Effects on Pathobiological Changes in A Rat Model of Diabetes Mellitus
Caesalpinia bonduc (L) Roxb is a medicinal plant commonly utilized in traditional Indonesian medicine, particularly for the treatment of diabetes mellitus (DM). This study examined the effects of varying doses C. bonduc extract on fasting blood sugar (FBS), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), and pancreatic histology in male and female wistar rats with diabetes. The study design included six groups of 18 male and female rats (Wistar strain) each. To develop diabetes, nicotinamide (NA) (110 mg/kg) and streptozotocin (STZ) (45 mg/kg) were supplied, followed by oral administration of C. bonduc extract at dosages of 200, 400, and 600 mg/kg for 21 days. We utilized ELISA to analyze biochemical parameters and employed H&E staining to evaluate histological changes. A factorial design was employed for the statistical analysis to examine the effects of both dosage and sex. This study offers a unique comparative examination of the antidiabetic efficacy of C. bonduc across genders, a dimension seldom explored in experimental diabetes research. The findings indicated that C. bonduc markedly reduced levels of FBS, MDA, TNF-α, and TGF-β (p < 0.05) enhanced the structural integrity of the pancreas. There were no significant differences between males and female (p > 0.05). The dosage and sex influenced MDA and TGF-β. The extract of C. bonduc shown the ability to lower blood sugar, fight free radicals, and reduce inflammation; however, the intensity of these benefits depended on the dosage given. This means that it might assist persons with diabetes minimize oxidative stress and damage to the pancreas.
- 17 January 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (2) , 623-650
Open AccessCaesalpinia bonduc (L) Roxb Seed Extract Dosage and Sex Effects on Pathobiological Changes in A Rat Model of Diabetes Mellitus
Caesalpinia bonduc (L) Roxb is a medicinal plant commonly utilized in traditional Indonesian medicine, particularly for the treatment of diabetes mellitus (DM). This study examined the effects of varying doses C. bonduc extract on fasting blood sugar (FBS), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), and pancreatic histology in male and female wistar rats with diabetes. The study design included six groups of 18 male and female rats (Wistar strain) each. To develop diabetes, nicotinamide (NA) (110 mg/kg) and streptozotocin (STZ) (45 mg/kg) were supplied, followed by oral administration of C. bonduc extract at dosages of 200, 400, and 600 mg/kg for 21 days. We utilized ELISA to analyze biochemical parameters and employed H&E staining to evaluate histological changes. A factorial design was employed for the statistical analysis to examine the effects of both dosage and sex. This study offers a unique comparative examination of the antidiabetic efficacy of C. bonduc across genders, a dimension seldom explored in experimental diabetes research. The findings indicated that C. bonduc markedly reduced levels of FBS, MDA, TNF-α, and TGF-β (p < 0.05) enhanced the structural integrity of the pancreas. There were no significant differences between males and female (p > 0.05). The dosage and sex influenced MDA and TGF-β. The extract of C. bonduc shown the ability to lower blood sugar, fight free radicals, and reduce inflammation; however, the intensity of these benefits depended on the dosage given. This means that it might assist persons with diabetes minimize oxidative stress and damage to the pancreas.